Starry(SH:603520) Xin Lang Cai Jing·2026-01-20 02:43Group 1 - The stock of Zhejiang Sitaili Pharmaceutical Co., Ltd. increased by 5.04% on January 20, reaching a price of 10.84 CNY per share, with a trading volume of 85.33 million CNY and a turnover rate of 1.83%, resulting in a total market capitalization of 4.75 billion CNY [1] - The company, established on September 15, 1997, and listed on March 9, 2016, specializes in the production and sales of non-ionic iodine contrast agents and quinolone raw materials, with the main business revenue composition being 79.73% from contrast agents, 10.19% from other supplementary products, 6.16% from other sources, 2.41% from CMO/CDMO, and 1.52% from quinolone series [1] Group 2 - According to data from the top ten holdings of funds, one fund under Nuoan Fund holds a significant position in Sitaili, specifically the Nuoan Theme Selected Mixed Fund (320012), which held 720,100 shares in the third quarter, accounting for 4.53% of the fund's net value, ranking as the tenth largest holding [2] - The Nuoan Theme Selected Mixed Fund (320012), established on September 15, 2010, has a current size of 173 million CNY, with a year-to-date return of 16.87% and a one-year return of 45.31%, ranking 213 out of 8,846 and 2,545 out of 8,091 respectively [2] - The fund manager, Luo Chunlei, has been in position for 10 years and 120 days, with the fund's total asset size at 173 million CNY, achieving a best return of 127.25% and a worst return of 2.88% during the tenure [2]